Home » Authors » Karen Young

Articles by Karen Young

Nereus Looking To The Ocean For New Compound Discovery

Feb. 5, 2002

Nereus Looking To The Ocean For New Compound Discovery

Feb. 5, 2002

CombinatoRx’s Approach Is Targeting Multiple Pathways

Feb. 5, 2002

Pozen Starts Phase III Of MT 300 For Treating Severe Migraine

Feb. 4, 2002

Pozen Starts Phase III Of MT 300 For Treating Severe Migraine

Feb. 4, 2002

Digene Raises $15M Through Stock Sale To Acqua Wellington

Feb. 1, 2002

Digene Raises $15M Through Stock Sale To Acqua Wellington

Feb. 1, 2002

IntraBiotics Netting $13.9M From Private Deal For Iseganan Studies

Jan. 31, 2002

IntraBiotics Netting $13.9M From Private Deal For Iseganan Studies

Jan. 31, 2002

Achillion Closes $41M Round, Plans Phase III Trials This Year

Jan. 29, 2002

Achillion Pharmaceuticals Inc. raised $41 million in a private round of financing that its CEO expects will allow it to take its lead anti-infective compound through Phase II trials and into Phase III before year’s end.